Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T12:54:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now loads a 403 Forbidden error page, replacing the previous study record content. As a result, the detailed study information and related sections are no longer accessible.
    Difference
    20%
    Check dated 2026-09-19T19:25:19.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous Revision: v3.6.5 on the page, indicating a small update to the page’s metadata/UI.
    Difference
    0.0%
    Check dated 2026-08-29T20:26:57.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor system update. This does not change any study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T14:52:26.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a small update to the page’s version. It reflects a new version of the page content or layout without altering the study details presented.
    Difference
    0.0%
    Check dated 2026-07-25T08:24:11.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, signaling a slight update to the content or backend metadata without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-07-03T22:40:31.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.